Primary endpoint met in phase II study of garadacimab as preventive treatment in HAE June 9, 2020 No Comments
FDA clears Expression Therapeutics' IND for phase I trial of gene therapy for hemophilia A May 28, 2020 No Comments
In vivo data support human trials of CRISPR/Cas9-mediated homology-directed repair treatment for SCD May 28, 2020 No Comments
Protagonist Therapeutics reports initial phase II data on PTG-300 in polycythemia vera May 8, 2020 No Comments
RSS